SCYNEXIS, Inc.

US$3.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SCYXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (34.86%)
Div yield —
ROE (21.16%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.22
PE TTM —
TSR TTM (33.71%)
Mkt cap US$34.82M
ROIC (168.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.48
(0.47%)
42.05%
Hold 1|11|8|3|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
27.56%
23.23%
8.26%
0.25%
Revenue$M
2.479
2.492
2.435
2.508
0.19%
(2.46%)
(3.41%)
(0.53%)
Peers (US$34.82M)
Cap (US$)
PE
26.95M
—
Capital
TTM
5Y
10Y
Leveragex
0.610
1.748
1.176
EBIT/Intx
1.359
3.996
3.448
Own earn%
157.85
96.21
88.78
Sh yield%
45.65
34.04
33.32
Owners
Insiders/Inst%
13.91
23.23
Short interest%
3.40
SBC / revenue%
3.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
2–9
$1 testx
−0.4
Incr. ROIC%
3